M L 22
Pill imprint M L 22 has been identified as Lisinopril 2.5 mg.
Lisinopril is used in the treatment of high blood pressure; heart failure; heart attack; diabetic kidney disease; migraine prevention (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Lisinopril 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Lisinopril Images
- Imprint:
-
M
L 22 - Strength:
- 2.5 mg
- Color:
- Blue
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
povidone
corn starch
sodium lauryl sulfate
FD&C Blue No. 2
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-2072
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0256 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Lisinopril resources
- Lisinopril
- Lisinopril (Wolters Kluwer)
- lisinopril (Cerner Multum)
- lisinopril (Micromedex) - Includes Dosage Information
- Lisinopril (AHFS DI)
- Lisinopril (FDA)
- Lisinopril (Wolters Kluwer)
Search Again
